Te Arai Rare Disorders Medicines recommended for PHARMAC funding
The PHARMAC Rare Disorders Subcommittee met November 5 and 6 2018 to consider the funding of Medicines for the treatment of Rare...
NEWS
- Jan 30, 2019
New recommendation for PHARMAC to fund sapropterin for PKU patients
The Medicine sapropterin has been recommended to be funded by PHARMACs Pharmacology and Therapeutics Advisory Committee (PTAC)....
- May 24, 2018
New Medicine Sapropterin Registered
The Te Arai BioFarma pharmaceutical product sapropterin has been registered by Medsafe for supply to New Zealanders. Registration...